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http://www.behavioralandbrainfunctions.com/content/10/1/29RESEARCH Open AccessStuttering candidate genes DRD2 but not SLC6A3
is associated with developmental dyslexia in
Chinese population
Huan Chen1†, Guoqing Wang2,3†, Jiguang Xia2,3, Yuxi Zhou2,3, Yong Gao2,3, Junquan Xu2,3, Michael SY Huen4,
Wai Ting Siok5,6, Yuyang Jiang7, Li Hai Tan8,9* and Yimin Sun2,3,7,10*Abstract
Background: Dyslexia is a polygenic developmental disorder characterized by difficulties in reading and spelling
despite normal intelligence, educational backgrounds and perception. Increasing evidences indicated that dyslexia
may share similar genetic mechanisms with other speech and language disorders. We proposed that stuttering
candidate genes, DRD2 and SLC6A3, might be associated with dyslexia.
Methods and results: The study was conducted in an unrelated Chinese cohort with 502 dyslexic cases and 522
healthy controls. In total, 23 Tag SNPs covering the two genes were selected for genotyping through Tagger
program. Association analysis was performed on each SNP alone and in haplotypes. One SNP markers in DRD2
showed significant association with developmental dyslexia.
Conclusion: These findings indicate that polymorphism of DRD2 gene may be a risk factor of developmental
dyslexia in the Chinese population.
Keywords: Dyslexia, Dopamine D2 receptor (DRD2), Solute carrier family 6, member 3 (SLC6A3), Linkage studyIntroduction
Speech and language defects can be characterized as
expressive (production), as receptive (comprehension)
or as mixed [1]. The emergence of genetic factors im-
plicated across multiple speech and language disorders
suggested that these disorders might share similar
underlying genetic mechanisms. Dyslexia, characterized
by difficulties in reading and spelling despite of normal
intelligence and adequate education background, is a
polygenic developmental disorder affecting about 5% to
10% school-aged children in the United States [2,3].
Though language disorders such as dyslexia are quite
different concept from speech disorders, in many cases,
it is difficult to discriminate a language disorder from a
speech disorder in a specific individual [1]. Goulandris* Correspondence: tanlh@hku.hk; ymsun@capitalbio.com
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unless otherwise stated.and his colleagues conducted a comparison study between
two groups of adolescents (group one with a childhood
history of language impairment, group two with develop-
mentally dyslexic) and showed that the adolescents with
dyslexia were indistinguishable from those with language
impairments according to their test scores of spoken and
written language skills. Moreover, both dyslexic adoles-
cents and those with language impairments showed
deficiency in phonological awareness [4]. Besides, some
studies revealed that motor defects may occur in both
defects and therefore might explain how the two defects
are connected [5,6]. As such, genes contributing to a speech
disorder are recognized as putative candidate genes for a
language disorder as well.
An example is the discovery of forkhead box P2 (FOXP2)
and its target genes. FOXP2 gene, which encodes a neurally
expressed transcription factor, was discovered through
linkage analysis of a large family who had developmental
verbal dyspraxia (DVD) or childhood apraxia of speech
(CAS) [7,8]. Subsequent reports provided additionaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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for other speech disorders and language disorders includ-
ing specific language impairment (SLI) and dyslexia, and
suggested that FOXP2 acts as an important hub in net-
works with relevance to speech and language disorders
[9-14]. Contactin associated protein-like 2 (CNTNAP2)
gene, a downstream target gene of FOXP2, encodes a
cell-surface neurexin protein with crucial roles in brain
development. Recent studies have shown that variants
of the CNTNAP2 gene are risk factors for speech and
language disorders including SLI, stuttering and dyslexia
[15-18]. Moreover, as reviewed in a recent study, the
dyslexia candidate genes including KIAA0319, double-
cortin domain containing 2 (DCDC2) and roundabout
homolog 1 (ROBO1) are candidate genes involved in
speech sound disorder (SSD) as well [19].
Dopamine, a monoamine neurotransmitter, is released
from synaptic vesicles and regulates motivation, locomo-
tion, cognition and reward-associated functions. Dopamine
transporter (DAT), the major regulator of extracellular
dopamine levels in the brain, controls the amplitude,
spatial and temporal dimensions of the dopaminergic
responses [20]. Dysregulation of dopaminergic system
has been implicated in a variety of pathological conditions
such as schizophrenia, Parkinsonism, attention deficit
hyperactivity disorder and drug addiction [20-22]. Dopa-
minergic function is considered to be critical for modula-
tion of the neural activity of striato-thalamo-cortical
circuit, which is involved in complex goal-directed or
context-dependent changes in human speech and bird
song output [23]. Moreover, dopaminergic system also
plays an important role in maintaining linguistic functions
such as speech fluency and reading, and a number of gen-
etic polymorphisms in the system have been identified as
important risk factors [24,25]. For instance, the dopamine
transporter gene (SLC6A3/DAT) has been implicated in
the pathogenesis of several speech and language disorders,
including dyslexia and stuttering [25,26]. Besides, a dys-
lexia susceptibility locus (DYX7) has been identified to
link to dopamine D4 receptor (DRD4) region on chromo-
some 11p15.5 in participants of European ancestry [27]. In
the mean time, association between DRD2 and stuttering
has been found in the Chinese population through high-
density genotyping [25].
Based on existing findings, dopaminergic genes DRD2
and SLC6A3 are believed to be candidate genes for dys-
lexia. In the present study, both genes were subjected to
association and linkage analysis for dyslexia. Although
the association of SLC6A3 with dyslexia has been reported
in a western study [26], it would be worthwhile to validate
the association of SLC6A3 with developmental dyslexia in
Chinese population due to the substantial differences
of linguistic and genetic backgrounds between Chinese
and other western populations. Therefore, we selectedtag SNPs covering above two genes and reported their
association with developmental dyslexia in a large un-
related Chinese cohort.
Materials and methods
Subjects
Dyslexic cases and healthy controls were selected by the
two-stage procedures, as previously described [28]. This
study was approved by the ethical committee of Tsinghua
University School of Medicine. All study subjects were in-
formed with written consents. First, 6,900 primary school
students from Shandong province of China were invited
to take a Chinese reading test, which consists of questions
on character-, word-, and sentence-level. Then, we se-
lected 1794 students with reading scores above 87th
percentile or below the 13th percentile in their grade
for further investigation. Second, to assess the reading
ability of these selected students, they were examined
individually by a character reading test consisting of 300
Chinese characters. Then the Raven’s Standard Test was
applied on all students to exclude participants with
intelligence deficiency. In the end, 1024 participants
(502 dyslexic cases and 522 controls) were chosen for
subsequent analysis.
SNP markers selection and genotyping
In total, 23 Tag SNPs covering DRD2 and SLC6A3 were
selected for genotyping through Tagger program [29].
The parameters were minor allele frequency (MAF) over
5% and pairwise r2 threshold of 0.8. SNP Genotyping
was performed using the Sequenom MassARRAY platform
(Sequenom, San Diego, CA) in CapitalBio Corporation
(Beijing, China). Briefly, saliva samples were collected and
subjected to genomic DNA extraction using Oragene™
DNA self-collection kit (DNA Genotek Inc., Ottawa,
Ontario, Canada) following the manufacturer’s instruc-
tions. DNA quality and quantity was determined by
Nanodrop spectrophotometry (Nanodrop 1000 Spectro-
photometer, Thermo Scientific, Wilmington, DE). Based
on a locus-specific primer extension reaction, a locus-
specific PCR reaction was designed using the MassAR-
RAY Assay Design software package (v3.1). MALDI-TOF
mass spectrometer and Mass ARRAY Type 4.0 software
were applied for mass determination and data acquisition.
Data analysis
Hardy-Weinberg equilibrium (HWE) tests were performed
for all SNPs individually. SNPs with a HWE P-value of less
than 0.00001 (in controls) were removed. PLINK software
was applied for association analysis using additive, domin-
ant, recessive and genotype models. Linkage disequilibrium
(LD) and haplotype analyses (haplotypes with above 0.01
frequence) were conducted using Haploview software
(Version 4.2), as previously described [30]. The Omnibus
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bus ANOVA test, the independent variable is haplotype
and the dependent variable is group (dyslexia or not). In
the single marker and haplotype analysis, we build the
logistic regression model using genotype/haplotype as
variable. We also build the logistic regression model using
genotype/haplotype as variable and using age and sex as
covariate. Bonferonni correction was undertaken for the
23 SNPs that were adopted into the single site association
analysis.
Results
Single marker analysis of SNPs within DRD2
In DRD2 gene, we genotyped 11 Tag SNPs and found
nominal association (P < 0.05) of five SNPs with dyslexia
in our cohort (Table 1). The allele C of rs1079727, the
allele C of rs2002453, the allele C of rs2471851 and the
allele G of rs11214607 were more frequent in patients
with dyslexia than that in controls. SNP rs1079727 was
significantly associated with dyslexia under recessive
model (P = 0.009134, Odds Ratio, OR = 1.538) and in
homozygous genotype (P = 0.008425, OR = 1.638). SNP
rs2002453 was significantly associated with dyslexia in
homozygous genotype (P = 0.04169, OR = 1.4909). SNP
rs17115583 showed remarkable association with dys-
lexia under recessive model (P = 0.01465, OR = 0.7135)
and in heterozygous genotype (P = 0.009318, OR = 0.6841).
SNP rs11214607 also revealed remarkable association with
dyslexia under dominant model (P = 0.01663, OR = 1.365)
and in heterozygous genotype (P = 0.009318, OR = 0.6841).
When the results were adjusted for age and sex, only
SNP rs1079727 and SNP rs17115583 remained significant
under the same model (rs1079727, Padjusted = 0.001017,
OR = 1.816; SNP rs17115583, Padjusted = 0.01393, OR =
0.6914) and genotype (rs1079727, Padjusted = 0.001883,
OR = 1.8827; SNP rs17115583, Padjusted = 0.01156, OR =
0.6686) as before adjustment. In addition, we found
rs2002453 and rs2471851 achieved significant level
under recessive model (rs2002453, Padjusted = 0.002867,
OR = 1.633; SNP rs2471851, Padjusted = 0.009401, OR =
1.67) and in homozygous genotype (rs2002453, Padjusted =
0.02866, OR = 1.5311; SNP rs2471851, Padjusted = 0.009509,
OR = 1.7458) after adjustment. Besides, rs11214607 was
significantly associated with dyslexia after adjustment for
age and sex in both recessive (Padjusted = 0.03885, OR =
1.53) and dominant (Padjusted = 0.01696, OR = 1.398)
models, the association became significant after adjust-
ment in homozygous genotype (Padjusted = 0.008440,
OR = 1.8187) other than in heterozygous genotype.
After the Bonferonni correction for multiple comparisons,
only SNP rs1079727 significantly associated with dyslexia
under recessive models (rs1079727, Padjusted = 0.023, OR =
1.8160), indicating that rs1079727 is a potential SNP
marker for a risk evaluation in dyslexia.Single marker analysis of SNPs within SLC6A3
In SLC6A3, we genotyped 12 Tag SNPs and found nom-
inal association of one SNP with dyslexia before adjust-
ment (Table 2). The allele A of rs11133762 was more
frequent in patients with dyslexia than that in controls.
SNP rs11133762 was significantly associated with dyslexia
under recessive model (P = 0.04247, OR = 1.5096). After the
adjustment of age and sex, SNP rs11133762 remained sig-
nificant under recessive model (P = 0.04395, OR = 1.5575).
However, none SNPs was significantly associated with
dyslexia after the Bonferonni correction. Thus, there
was no significant finding for dyslexia with any of the
SNP markers.
Haplotype analysis
In DRD2, haplotype analysis was conducted in three
blocks (Figure 1 and Additional file 1: Table S1). Block 1
consisting of rs1079727, rs2002453, rs2471851 and
rs12800853 was associated with dyslexia (P = 0.022
Omnibus test), and included one risk haplotype CCCC
(Punadjusted = 0.00367, OR = 1.22). The association for
haplotype CCCC remained significant after adjustment
for age and sex as covariates (Padjusted = 0.0146, OR = 1.28).
And one protective haplotype TTAC (Padjusted = 0.0327,
OR = 0.812) was identified after adjustment for age and
sex. Block 2 consisting of rs17115583 and rs11214607 was
associated with dyslexia (P = 0.0387 Omnibus test), and
included one risk haplotype GG (Punadjusted = 0.0425,
OR = 1.21). The association for haplotype GG also
remained remarkable after adjustment for age and sex
(Padjusted = 0.0142, OR = 1.29). However, the above P-values
failed to reach significance after the Bonferonni adjustment
for multiple comparisons. Meanwhile, in SLC6A3, we
identified 3 haplotypes (Figure 2), but no significant haplo-
type associations were found before or after adjustment
(Additional file 1: Table S2).
Discussion
Dopaminergic system has a major role in fine motor
movements, and dysfunction of central dopaminergic
neurotransmission has been associated with the devel-
opment of speech and language [25,31-33]. Here, we
aimed to examine the association between dyslexia and
dopaminergic genes (dopamine receptor DRD2 and
dopamine transporter SLC6A3). In DRD2 gene, using a
recessive model, we demonstrated that rs1079727 was
significantly associated with dyslexia with the allele C
as a risk factor after Bonferonni correction. Haplotype
analysis also suggested association between the risk
haplotype CCCC of rs1079727-rs2002453-rs2471851-
rs12800853 (Block 1) and dyslexia, but the p-value failed to
reach significance after the Bonferonni correction. All
four SNPs in Block1 located in the intron region of
DRD2 gene, with rs1079727-rs2002453 in intron 2 and
Table 1 Association between SNPs in DRD2 and dyslexia using the additive, dominant, genotype, and the recessive
models
SNP Patient Control CrudeOR (95%CI) Unadjusted
Adjusted
OR (95%CI)
Adjusted
p-value
Bonferroni
corrected p-value
rs2440390
C Allele 930 975 1 1
T Allele 36 45 0.8436(0.5432-1.31) 0.4488 0.7823(0.4875-1.256) 0.3091 1
CC 449 466 1 1
CT 32 43 0.7724(0.4800-1.2427) 0.2870905 0.7092(0.4247-1.1843) 0.18903 1
TT 2 1 2.0757(0.1877-22.9491) 0.5513879 1.8799(0.1540-22.9427) 0.62095 1
Dom 0.802(0.5033-1.278) 0.3533 0.7372(0.446-1.218) 0.2342 1
Rec 2.116(0.1913-23.42) 0.541 1.928(0.1574-23.6) 0.6076 1
rs1079727
T Allele 521 606 1 1
C Allele 445 414 1.254(1.048-1.501) 0.01345 1.337(1.1-1.626) 0.003592 0.0828
TT 143 174 1 1
CT 235 258 1.10831(0.8350-1.4711) 0.4765734 1.0949(0.8061-1.4871) 0.561809 1
CC 105 78 1.6380(1.1347-2.3645) 0.0084253 1.8827(1.2633-2.8059) 0.001883 0.0437*
Dom 1.231(0.9421-1.609) 0.1277 1.269(0.9509-1.694) 0.1056 1
Rec 1.538(1.113-2.127) 0.009134 1.816(1.272-2.592) 0.001017 0.023*
rs2002453
T Allele 476 539 1 1
C Allele 490 475 1.169(0.9793-1.396) 0.0838 1.238(1.022-1.5) 0.02946 0.6785
TT 123 136 1 1
CT 230 267 0.9525(0.7049-1.2869) 0.7511201 0.9340(0.6743-1.2938) 0.681255 1
CC 130 104 1.3821(0.9692-1.9710) 0.073918 1.5311(1.0454-2.2424) 0.028655 0.6601
Dom 1.073(0.8079-1.425) 0.6269 1.1(0.81-1.494) 0.5414 1
Rec 1.427(1.063-1.916) 0.01806 1.633(1.183-2.253) 0.002867 0.0667
rs2471851
A Allele 565 641 1 1
C Allele 399 377 1.205(1.004-1.446) 0.04551 1.269(1.041-1.549) 0.01864 0.4278
AA 165 198 1 1
AC 235 245 1.1510(0.8757-1.5128) 0.3131888 1.1008(0.8188-1.4799) 0.524907 1
CC 82 66 1.4909(1.0151-2.1897) 0.0416912 1.7458(1.1457-2.6601) 0.009509 0.2185
Dom 1.223(0.9439-1.585) 0.1276 1.225(0.9262-1.62) 0.1548 1
Rec 1.376(0.9685-1.955) 0.07486 1.67(1.134-2.459) 0.009401 0.2162
rs12800853
C Allele 921 959 1 1
T Allele 43 61 0.7304(0.4877-1.094) 0.1276 0.723(0.4698-1.113) 0.1403 1
CC 439 451 1 1
CT 43 57 0.7750(0.5107-1.1762) 0.2310594 0.7807(0.4999-1.2194) 0.276544 1
TT 0 2 NA NA
Dom 0.7487(0.4947-1.133) 0.1711 0.7476(0.4802-1.164) 0.1978 1
Rec
rs17115583
G Allele 560 549 1 1
A Allele 406 459 0.8636(0.7207-1.035) 0.1119 0.8382(0.6894-1.019) 0.07648 1
GG 167 138 1 1
AG 226 273 0.6841(0.5138-0.9108) 0.009318 0.6686(0.4892-0.9138) 0.01156 0.2668
AA 90 93 0.7997(0.5539-1.1545) 0.2328118 0.7555(0.5102-1.1189) 0.161701 1
Dom 0.7135(0.544-0.9356) 0.01465 0.6914(0.5152-0.9279) 0.01393 0.3197
Rec 1.012(0.7341-1.395) 0.9416 0.9593(0.6786-1.356) 0.8141 1
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Table 1 Association between SNPs in DRD2 and dyslexia using the additive, dominant, genotype, and the recessive
models (Continued)
rs11214607
T Allele 589 674 1 1
G Allele 377 346 1.247(1.038-1.499) 0.01845 1.324(1.084-1.616) 0.005965 0.138
TT 177 225 1 1
GT 235 224 1.3336(1.0192-1.7450) 0.0358259 1.3111(0.9822-1.7501) 0.066015 1
GG 71 61 1.4796(0.9969-2.1958) 0.0517832 1.8187(1.1654-2.8382) 0.00844 0.1932
Dom 1.365(1.058-1.761) 0.01663 1.398(1.062-1.84) 0.01696 0.391
Rec 1.268(0.8785-1.832) 0.2045 1.53(1.022-2.292) 0.03885 0.8947
rs12574471
C Allele 831 873 1 1
T Allele 135 143 0.9917(0.7683-1.28) 0.9488 0.9854(0.7477-1.299) 0.9166 1
CC 358 373 1 1
CT 115 127 0.9435(0.7052-1.2621) 0.6950158 0.9483(0.6924-1.2988) 0.740855 1
TT 10 8 1.3024(0.5083-3.3372) 0.5821073 1.2050(0.4383-3.3130) 0.717837 1
Dom 0.9647(0.7268-1.281) 0.8037 0.9643(0.7098-1.31) 0.8162 1
Rec 1.321(0.5171-3.376) 0.5605 1.218(0.4417-3.359) 0.703 1
rs4274224
A Allele 811 833 1 1
G Allele 155 187 0.8478(0.6689-1.075) 0.1723 0.8359(0.6466-1.081) 0.1713 1
AA 338 339 1 1
AG 135 155 0.8735(0.6631-1.1507) 0.3362564 0.8612(0.6392-1.1602) 0.325729 1
GG 10 16 0.6268(0.2805-1.4010) 0.2550209 0.6131(0.2577-1.4590) 0.268747 1
Dom 0.8505(0.6507-1.111) 0.2356 0.8399(0.6288-1.122) 0.2374 1
Rec 0.6527(0.2933-1.453) 0.296 0.6246(0.2631-1.483) 0.2862 1
rs7131056
C Allele 562 583 1 1
A Allele 402 437 0.9565(0.8039-1.138) 0.6159 0.9669(0.8009-1.167) 0.7259 1
CC 166 177 1 1
AC 230 229 1.0709(0.8095-1.4168) 0.6313223 1.0434(0.7684-1.4168) 0.78544 1
AA 86 104 0.8817(0.6179-1.2582) 0.4877891 0.9131(0.6228-1.3387) 0.64142 1
Dom 1.012(0.7788-1.315) 0.9298 1.005(0.7573-1.333) 0.9743 1
Rec 0.8478(0.6172-1.165) 0.308 0.8876(0.6292-1.252) 0.4969 1
rs72999677
G Allele 679 730 1 1
C Allele 287 290 1.059(0.8792-1.275) 0.5477 1.099(0.8983-1.343) 0.3599 1
GG 245 273 1 1
CG 189 184 1.14457(0.8769-1.4939) 0.320458 1.1395(0.8519-1.5242) 0.378904 1
CC 49 53 1.0302(0.6735-1.5758) 0.8909049 1.1518(0.7287-1.8206) 0.545185 1
Dom 1.119(0.8722-1.436) 0.3766 1.143(0.8731-1.496) 0.3307 1
Rec 0.9735(0.6461-1.467) 0.8979 1.1(0.7044-1.716) 0.6762 1
*P < 0.05, Bold data: adjusted p value < 0.05.
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SNP rs1079727 has been associated with other com-
mon childhood-onset neurodevelopmental disorders
including schizophrenia (SCZ) and attention-deficit/
hyperactivity disorder (ADHD), which affected about
5% school-aged children [34-37]. Thus the significant
association between SNP rs1079727 and dyslexia as well
as other neurodevelopmental disorders might be an indi-
cation of its regulatory function in gene transcriptionregulation. To further define the loci associated with
dyslexia, we also performed an imputation analysis (data
not shown), which revealed that SNP rs1076560 and
rs2283265 were significantly associated with dyslexia
(rs1076560, P = 0.04246; rs2283265, P = 0.04196). The
intronic SNP rs2283265 and SNP rs1076560 have been
shown to affect alternative splicing of DRD2 transcript,
and both SNPs were also associated with activity of the
ventral striatum and prefrontal cortex during working
Table 2 Association between SNPs in SLC6A3 and dyslexia using the additive, dominant, genotype, and the recessive
models
SNP Patient Control CrudeOR (95%CI)
Unadjusted
p-value
Adjusted
OR (95%CI)
Adjusted
p-value
Bonferroni
corrected p-value
rs11133762
C Allele 552 629 1 1
T Allele 386 363 1.222(1.013-1.475) 0.03628 1.232(1.004-1.511) 0.04568 1
CC 158 194 1 1
CT 236 241 1.2024(0.9121-1.5850) 0.19106664 1.1500(0.8517-1.5527) 0.361697 1
TT 75 61 1.5096(1.0141-2.2474) 0.04246577 1.5575(1.0121-2.3967) 0.043953 1
Dom 1.264(0.972-1.645) 0.08041 1.235(0.9291-1.642) 0.1461 1
Rec 1.357(0.9429-1.954) 0.1002 1.46(0.9799-2.175) 0.06285 1
rs3863145
G Allele 925 974 1 1
A Allele 37 44 0.8916(0.5778-1.376) 0.604 0.935(0.5856-1.493) 0.7783 1
GG 445 468 1 1
AG 35 38 0.9687(0.6011-1.5610) 0.89593367 1.0151(0.6043-1.7051) 0.954917 1
AA 1 3 0.3506(0.0364-3.3758) 0.36433775 0.4064(0.0394-4.1922) 0.449521 1
Dom 0.9234(0.5794-1.472) 0.7376 0.9701(0.5851-1.608) 0.9063 1
Rec 0.3514(0.03643-3.39) 0.3658 0.4136(0.0402-4.256) 0.458 1
rs40184
C Allele 734 796 1 1
T Allele 232 218 1.151(0.9343-1.417) 0.1867 1.127(0.9-1.411) 0.2976 1
CC 281 314 1 1
CT 172 168 1.1440(0.8763-1.4937) 0.32260995 1.0956(0.8214-1.4613) 0.53434 1
TT 30 25 1.3409(0.7701-2.3350) 0.29988039 1.3203(0.7261-2.4007) 0.362334 1
Dom 1.17(0.9067-1.509) 0.228 1.128(0.8567-1.485) 0.3909 1
Rec 1.277(0.7396-2.204) 0.3804 1.306(0.7249-2.355) 0.3738 1
rs6869645
C Allele 939 987 1 1
T Allele 27 33 0.8604(0.5137-1.441) 0.5677 0.8694(0.4988-1.515) 0.6214 1
CC 456 478 1 1
CT 27 31 0.9130(0.5365-1.5539) 0.73717584 0.9431(0.5296-1.6794) 0.842233 1
TT 0 1 NA NA
Dom 0.8845(0.5216-1.5) 0.6486 0.9032(0.5099-1.6) 0.7273 1
Rec NA NA
rs40358
A Allele 617 643 1 1
C Allele 347 375 0.9625(0.7976-1.161) 0.6899 0.9412(0.768-1.154) 0.5595 1
AA 190 199 1 1
AC 237 245 1.01329(0.7756-1.3235) 0.92355677 0.9603(0.7183-1.2838) 0.784396 1
CC 55 65 0.8862(0.5879-1.3360) 0.56412977 0.8738(0.5617-1.3593) 0.549582 1
Dom 0.9866(0.7644-1.273) 0.9172 0.945(0.7171-1.245) 0.6877 1
Rec 0.8798(0.6-1.29) 0.5123 0.8838(0.5843-1.337) 0.5587 1
rs10052016
A Allele 861 923 1 1
G Allele 101 93 1.167(0.8654-1.575) 0.3109 1.098(0.7937-1.52) 0.5712 1
AA 385 418 1 1
AG 91 87 1.1356(0.8206-1.5715) 0.44286861 1.0895(0.7663-1.5492) 0.632995 1
GG 5 3 1.8095(0.4297-7.6209) 0.41883352 1.3168(0.2851-6.0832) 0.724443 1
Dom 1.158(0.8417-1.594) 0.3674 1.098(0.7764-1.552) 0.5977 1
Rec 1.768(0.4203-7.439) 0.4369 1.297(0.2802-6.001) 0.7396 1
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Table 2 Association between SNPs in SLC6A3 and dyslexia using the additive, dominant, genotype, and the recessive
models (Continued)
rs403636
C Allele 645 677 1 1
A Allele 319 341 0.9808(0.8089-1.189) 0.8435 0.9492(0.7711-1.168) 0.6232 1
CC 208 220 1 1
AC 229 237 1.0220(0.7860-1.3288) 0.87099199 1.0459(0.7870-1.3900) 0.756883 1
AA 45 52 0.9153(0.5884-1.4238) 0.6946183 0.7948(0.4921-1.2836) 0.347614 1
Dom 1.003(0.7798-1.29) 0.9826 0.9992(0.7614-1.311) 0.9952 1
Rec 0.905(0.5946-1.377) 0.6413 0.7838(0.4989-1.232) 0.2907 1
rs2937639
T Allele 816 878 1 1
C Allele 150 142 1.136(0.8864-1.456) 0.3137 1.128(0.8626-1.476) 0.3783 1
TT 344 379 1 1
CT 128 120 1.1752(0.8805-1.5684) 0.27303583 1.1803(0.8642-1.6120) 0.297244 1
CC 11 11 1.1017(0.4717-2.5736) 0.82287421 1.0280(0.4145-2.5496) 0.952512 1
Dom 1.169(0.8837-1.546) 0.2739 1.169(0.8636-1.582) 0.3123 1
Rec 1.057(0.4541-2.462) 0.8974 0.9771(0.3924-2.433) 0.9603 1
rs3756450
A Allele 506 535 1 1
G Allele 454 485 0.989(0.8238-1.187) 0.9055 1.018(0.8355-1.24) 0.8615 1
AA 124 133 1 1
AG 258 269 1.0287(0.7633-1.3864) 0.85244842 1.0910(0.7906-1.5055) 0.596073 1
GG 98 108 0.9733(0.6743-1.4047) 0.8849171 1.0310(0.6914-1.5373) 0.881023 1
Dom 1.013(0.7622-1.346) 0.9299 1.073(0.7889-1.458) 0.6547 1
Rec 0.9549(0.7023-1.298) 0.7685 0.9685(0.6952-1.349) 0.8497 1
rs2550946
A Allele 823 886 1 1
G Allele 143 134 1.148(0.8909-1.479) 0.2859 1.141(0.8671-1.501) 0.3463 1
AA 350 386 1 1
AG 123 114 1.1899(0.8877-1.5951) 0.24476629 1.2021(0.8760-1.6495) 0.254198 1
GG 10 10 1.1029(0.4536-2.6813) 0.82898896 1.0040(0.3872-2.6035) 0.99349 1
Dom 1.183(0.8902-1.572) 0.2468 1.186(0.8724-1.613) 0.2761 1
Rec 1.057(0.4361-2.563) 0.9022 0.9507(0.3652-2.475) 0.9176 1
rs12652860
C Allele 595 615 1 1
A Allele 371 403 0.9467(0.7832-1.144) 0.5712 0.9343(0.761-1.147) 0.5166 1
CC 173 174 1 1
AC 249 267 0.9380(0.7144-1.2314) 0.64476562 0.9233(0.6859-1.2428) 0.598692 1
AA 61 68 0.9022(0.6020-1.3523) 0.6183072 0.8904(0.5778-1.3720) 0.598766 1
Dom 0.9307(0.7169-1.208) 0.5898 0.9163(0.691-1.215) 0.544 1
Rec 0.9374(0.6472-1.358) 0.7326 0.9203(0.6162-1.374) 0.6849 1
rs12654851
G Allele 536 549 1 1
T Allele 430 471 0.9285(0.771-1.118) 0.4343 0.9315(0.7625-1.138) 0.4869 1
GG 137 136 1 1
GT 262 277 0.9389(0.7017-1.2564) 0.67158199 0.9964(0.7282-1.3633) 0.981816 1
TT 84 97 0.8597(0.5900-1.2525) 0.43094129 0.8456(0.5610-1.2747) 0.423275 1
Dom 0.9184(0.695-1.214) 0.5493 0.9584(0.7095-1.295) 0.782 1
Rec 0.8964(0.649-1.238) 0.5066 0.8546(0.6038-1.21) 0.3754 1
Bold data: adjusted p value < 0.05.
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Figure 1 Haplotype analysis of DRD2. (a) Linkage disequilibrium analysis of the 11 SNPs in DRD2 investigated in healthy controls. (b) Three
blocks were identified using Haploview software.
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http://www.behavioralandbrainfunctions.com/content/10/1/29memory [38]. Taken together, our data was in accordance
with a recent animal study which showed that altered
DRD2 expression correlated with selective cognitive im-
pairments in working memory and behavioral flexibility
[39]. Working memory represents temporary processing
and storage of information, and helps to coordinate differ-
ent behaviors and functions. It is well documented that
dyslexic individuals showed not only impairments withFigure 2 Haplotype analysis of SLC6A3. (a) Linkage disequilibrium analy
blocks were identified using Haploview software.language-specific skills but also working memory defects
[40-42]. Hence, it is conceivable that changes in the DRD2
genotype may eventually impair the working memory of
dyslexia children in our study.
SLC6A3 contains a 40 base pair variable number of
tandem repeats (VNTR) in the 3'-UTR region [43]. The
association between the 10-repeat SLC6A3 allele and neu-
rodevelopmental disorders (i.e., ADHD and dyslexia) hassis of the 12 SNPs in SLC6A3 investigated in healthy controls. (b) Three
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http://www.behavioralandbrainfunctions.com/content/10/1/29been reported [25,43-46]. In previous studies, only several
SNP markers in the 5’ region of this gene were identified
to be associated with ADHD by SNP genotyping, and
none were found in the 3’ region of the gene, including
the 3' VNTR and the VNTR of intron 8 [47,48]. In our in-
vestigation, we only identified one SNP marker in SLC6A3
showing significant association with dyslexia after adjust-
ment for age and sex, which located in the 3’- untranslated
region (3’-UTR). However, the evidence was no longer
apparent after Bonferonni adjustment for multiple com-
parisons. The inconsistent association of SLC6A3 with
dyslexia between our study and previous western studies
might be explained by linguistic and genetic differences
among various populations. English is an alphabetical
language while Chinese is logographic. Previous studies
found that brain regions associate with dyslexia in west-
ern populations and Chinese population might be differ-
ent. Dyslexia among western populations is associated
with dysfunction of left temporoparietal brain regions.
Differently, dyslexia among Chinese populations is asso-
ciated with the left middle frontal gyrus [49,50]. Given
the functional differences between these brain regions,
the underlying mechanisms of dyslexia among western
and Chinese populations might be different as well. But
this conclusion requires further validation among larger
independent Chinese dyslexia cohort.
Conclusion
In conclusion, we found significant association between
one SNP marker within DRD2 and development dyslexia
in a large unrelated Chinese cohort. Our finding supports
the involvement of DRD2 polymorphisms in the develop-
ment of dyslexia. However, further functional analyses are
required to explicate its biological roles underlying dys-
lexia etiology and pathology.
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